FinBoss.io
CSEN
  • Home
  • Crypto prices
  • Bitcoin on-chain
  • US macro
  • US stocks
  • Guides
  • How we make money
FinBoss.io
Home
Crypto prices
Bitcoin on-chain
Hashrate
Mining difficulty
Mining pools
Mempool and fees
On-chain activity
MVRV and NUPL
SOPR
Holders
Supply in profit
Rainbow Chart
Fair value
Pi Cycle Top
US macro
FedWatch
Interest rates
Treasury yields
Inflation
Liquidity and Bitcoin
Business cycle
US stocks
Stock screener
Earnings calendar
Insider trading
Market heatmap
Guides
How we make money
CSEN
Home
Stocks
Merck
Merck

Merck

MRKHealth care

Stock · Data from SEC EDGAR 13F · Held by 19 of 87 tracked investors

$145.27
▼ 1.34%
Famous investorshold 19buying 1selling 0
Price (USD)
$145.27
Market cap
$358B
P/E ratio
117.2
Tracked investors holding
19 of 87
Next earnings
–

Merck at a glance

An overview of the financial statements, in plain language. Switch to the advanced view for charts.

FinBoss score
53out of 100
  • Valuation8
  • Growth48
  • Profitability34
  • Quality66
  • Debt69
  • Stability94
In its favour
  • Nothing notable from the statements.

Earnings results

QuarterReportedEPSAnalyst estimateSurprise
Jun 20264 Aug 2026-0.13-0.26+50%
Mar 202630 Apr 2026-1.28-1.51+15.2%
Dec 20253 Feb 20262.042.03+0.5%
Sep 202530 Oct 20252.582.36+9.3%

EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.

7D
-0.47%
1M
-1.83%
3M
+10.83%
YTD
+36.47%
1Y
+66.04%
3Y
+41.29%
5Y
+64.99%
Forward P/E
15.7
Dividend yield
2.31%
52-week low
$82.01
52-week high
$156.92

Chart MRK

Insider purchases

last 90 days, SEC Form 4
Loading insider trades…

Which investors hold this stock

19
BN
Bill Nygren
Oakmark (Harris Associates)
2.06%$1,551,394,499▼ -2.4%
KF
Ken Fisher
Fisher Investments
1.47%$4,949,339,962▲ +45.7%
PW
Prem Watsa
Fairfax Financial Holdings
0.84%$22,198,631unchanged
CB
Christopher Bloomstran
Semper Augustus Investments
0.65%$5,735,341unchanged
Čn
Česká národní banka
Česká národní banka
0.54%$103,007,062▲ +0.8%
Ns
Norský státní fond
Norges Bank
0.47%$4,752,416,244New position
Šn
Švýcarská národní banka
Swiss National Bank
0.47%$896,062,754▼ -4.3%
CA
Cliff Asness
AQR Capital Management
0.36%$1,039,396,005▼ -5.7%
GI
Generali Investments CEE
Generali Investments CEE
0.17%$3,595,559unchanged
JG
Joel Greenblatt
Gotham Asset Management
0.16%$67,968,405▲ +4.4%
MG
Mario Gabelli
GAMCO Investors
0.07%$8,053,352▼ -3.2%
SC
Steven Cohen
Point72 Asset Management
0.05%$48,840,409▼ -58.7%
KG
Ken Griffin
Citadel Advisors
0.03%$248,476,210▼ -49.4%
IE
Israel Englander
Millennium Management
0.03%$72,127,307▼ -71.5%
RD
Ray Dalio
Bridgewater Associates
0.02%$3,887,639New position
JY
Jeff Yass
Susquehanna International Group
0.01%$115,203,720▼ -13.2%
RB
Ron Baron
Baron Capital
0%$2,827,000▼ -12%
TR
Thomas Russo
Gardner Russo & Quinn
0%$211,006▼ -23.3%
RP
Richard Pzena
Pzena Investment Management
0%$322,664unchanged

Frequently asked questions

How much is Merck (MRK) stock?

Merck shares trade at $145.27, -1.34% over the last trading day. The price is delayed.

What is the market cap of Merck?

The market cap of Merck is about $358B and its price-to-earnings ratio (P/E) is 117.2.

Does Merck pay a dividend?

The dividend yield of Merck is 2.31% a year. The yield can change with the company's decisions.

How has Merck stock performed over the last year?

The Merck share price changed by +66.04% over 12 months and by +64.99% over 5 years.

Which big investors hold Merck?

According to the latest 13F filings, 19 of 87 tracked investors hold Merck, for example Bill Nygren, Ken Fisher, Prem Watsa.

Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.

© 2026 FinBoss.io. All rights reserved.

How we make moneyTerms (Czech)Privacy (Czech)Cookies (Czech)

Disclaimer: the information on this site is for general information only and is not investment or financial advice. Investing involves risk, and cryptocurrencies are especially volatile. Past performance does not guarantee future results. Some links are affiliate links and are marked as ads.

What to watch
  • !Out of 100 USD of revenue, only 4.8 USD is left as net profit.
  • !It pays out more in dividends than it earns.
  • !The stock is expensive: you pay 117.2 USD for 1 USD of annual earnings.

The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.

Is the stock expensive?

Expensive

For 1 USD of annual earnings you pay 117.2 USD. Based on next year's estimates 15.7 USD.

P/E
117.2×
P/S
5.4×
EV/EBITDA
14.0×

Is the company growing?

Growing slowly
22
23
24
25

Revenue over 3 years grew 3.1% a year. Last year 5.1%.

Does it make money?

Weak
  • Cost of sales 25
  • Research 24.3
  • Operations and selling 16.5
  • Taxes and other 5.9
  • Net profit 28.1

Out of 100 USD of revenue, 28.1 USD is left as net profit.

Is it financially healthy?

Mostly
Cash
7.1B USD
Debt
53.9B USD
Free CF
15.2B USD

It could repay its net debt from free cash flow in 3.1 years.

Does it pay a dividend?

Risky
Yield
2.31%
Of earnings
267%

Over a year you receive roughly 2.31% of the price per share. The payout is more demanding for the company. It has raised the dividend for 9 years in a row.

What do analysts expect?

Buy
Average target
159.76 USD
Vs price
+10%

25 analysts. Their opinion is not a recommendation by FinBoss.io.

Which big investors hold it?

19 of 87

Among the tracked investors, Bill Nygren, Ken Fisher, Prem Watsa and others hold the stock according to 13F filings.

Revenue and net profit (USD B)

Margins (% of revenue)

Free cash flow and capex (USD B)

Cash and debt (USD B)

Earnings per share (EPS, USD)

Latest quarters (USD B)

Dividend per share by year (USD)

* the year has not ended yet. Source: Yahoo Finance.

Ratios

P/E
117.2×
Forward P/E
15.7×
P/B
8.6×
P/S
5.4×
PEG
2.75
EV/EBITDA
14.0×
Gross margin
75.9%
Operating margin
-0.2%
Net margin
4.8%
ROE
7.0%
ROA
11.9%
Debt / equity
1.3×
Current ratio
1.3×
Revenue growth
5.1%
Earnings growth
–
Beta
0.22
Dividend
2.31%
Payout ratio
267%